Westlake Chemical Partners LP has announced its third-quarter results for 2026, highlighting a significant increase in net income and cash flow. The Partnership reported net income attributable to the Partnership of $16.2 million, or $0.46 per limited partner unit, which is an improvement compared to $14.7 million in the same quarter last year. This growth is attributed to higher production and sales volumes, reflecting a positive trend in the industrial organic chemicals sector.
The company declared a quarterly distribution of $0.4714 per unit, marking the 49th consecutive quarterly distribution to its unitholders. This distribution is payable on December 1, 2026, to unitholders of record as of November 13, 2026. The MLP distributable cash flow for the third quarter was reported at $18.0 million, up from $14.9 million in the same quarter last year, indicating a robust coverage ratio of 1.09x.
Westlake Chemical Partners LP, which operates under the SIC code 2860 for Industrial Organic Chemicals, has been able to achieve these results through strategic management of its ethylene sales agreement with Westlake. This agreement ensures stable cash flows, as 95% of the Partnership's ethylene production is sold to Westlake for a cash margin of $0.10 per pound.
“We were pleased with the Partnership's performance in the third quarter of 2026, with net income, EBITDA, and MLP distributable cash flow all increasing from the second quarter,” said Jean-Marc Gilson, President and Chief Executive Officer. He expressed optimism for future earnings and cash flows, which are expected to benefit from the stability provided by their ethylene sales agreement.
The Partnership's cash flows from operating activities for the third quarter were $122.2 million, an increase from $105.2 million in the third quarter of 2025. However, cash flows from operating activities decreased by $7.6 million compared to the second quarter of 2026 due to less favorable working capital changes.
Looking ahead, the company plans to continue leveraging its operational strengths and market position to enhance profitability. The upcoming conference call scheduled for November 4, 2026, will provide further insights into the Partnership's performance and strategic direction.
Details were not available in the SEC filing regarding any upcoming changes or initiatives beyond the announced financial results.
Read Next
MGE Energy reports stable Q3 results amid industry changes
Clear Secure reports Q3 2026 results, highlights growth
Clene Inc. reports Q3 2026 results, focuses on growth
Aprea Therapeutics reports Q3 2026 results, updates on trials
Clene Inc. Reports Third Quarter Results and Key Updates
Rand Capital Corp announces third-quarter 2026 results




